Lloyds Banking Group’s Boston Scientific BSX Stock Holding History

Lloyds Banking Group’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-36,574	Closed	-$431K	–	109
2014 Q3	$431K	Sell	36,574 -8,716	-19%	-$110K	0.12%	188
2014 Q2	$578K	Sell	45,290 -450,488	-91%	-$5.86M	0.14%	171
2014 Q1	$6.7M	Sell	495,778 -203,098	-29%	-$2.67M	0.06%	256
2013 Q4	$8.4M	Buy	698,876 +207,819	+42%	+$2.46M	0.08%	228
2013 Q3	$5.76M	Sell	491,057 -41	-0%	-$443	0.06%	240
2013 Q2	$4.55M	Buy	+491,098	New	+$4.17M	0.05%	268

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Lloyds Banking Group's BSX Position: Q4 2014 in Review

Lloyds Banking Group sold out of Boston Scientific (BSX) in Q4 2014, closing a stake of 36,574 shares — an estimated $431K sold.

Lloyds Banking Group first reported a position in BSX in Q2 2013 and held it in 6 quarters. The position peaked at $8.4M in Q4 2013. 457 funds tracked by Wall St. Rank hold BSX as of Q4 2014.

Lloyds Banking Group reported no remaining Boston Scientific position as of Q4 2014 after selling out during the quarter.
Lloyds Banking Group sold 36,574 Boston Scientific shares in Q4 2014, an estimated $431K.
Lloyds Banking Group first reported a position in Boston Scientific in Q2 2013 and held it in 6 quarters.
Lloyds Banking Group's Boston Scientific position peaked at $8.4M in Q4 2013.
457 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2014.

Based on Lloyds Banking Group's 13F filing for Q4 2014, filed 12 Feb 2015.